ClassID:

96898

C07K14/47 - page 11 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3001
20150037294
2015-02-05

Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1

#3002
20150037283
2015-02-05

Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases

#3003
20150031618
2015-01-29

Muteins of αm lipocalin and method of production therefor

#3004
20150031604
2015-01-29

Cyclic polypeptides for the treatment of heart failure

#3005
20150030595
2015-01-29

Myostatin inhibitor comprising extracellular water-soluble domains of DLK1 as active ingredient

#3006
20150030594
2015-01-29

Bioconjugates of synthetic apelin polypeptides

#3007
20150025225
2015-01-22

Monoclonal antibody against EL which inhibits enzyme activity of EL

#3008
20150025128
2015-01-22

Method for producing protein

#3009
20150025018
2015-01-22

Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence

#3010
20150025016
2015-01-22

Peptides that inhibit the interaction between ASF1 and histones, and use thereof

#3011
20150024462
2015-01-22

Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin

#3012
20150024458
2015-01-22

Dock-and-lock (DNL) complexes for therapeutic and diagnostic use

#3013
20150023932
2015-01-22

ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF

#3014
20150023920
2015-01-22

NOVEL COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CANCER METASTASIS

#3015
20150023870
2015-01-22

Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases

#3016
20150018521
2015-01-15

Endoplasmic reticulum localization signals

#3017
20150018282
2015-01-15

PREPARATION FOR IMPROVING MEMORY AND LEARNING AND USE THEREOF

#3018
20150018267
2015-01-15

Endomucin as an anti-inflammatory agent

#3019
20150018229
2015-01-15

POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

#3020
20150017739
2015-01-15

Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers

#3021
20150017193
2015-01-15

RAB6KIFL/KIF20A epitope peptide and vaccines containing the same

#3022
20150017161
2015-01-15

Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonist

#3023
20150017146
2015-01-15

Method of enhancing efficacy of blood transfusions

#3024
20150011729
2015-01-08

NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF

#3025
20150011594
2015-01-08

BIN1 expression as a marker of cancer

#3026
20150011474
2015-01-08

Polypeptides binding to human complement C5

#3027
20150011017
2015-01-08

Diagnosis and risk stratification by determining the marker CT-proADM

#3028
20150010946
2015-01-08

Polynucleotides encoding ZCYTOR17 ligand antibodies

#3029
20150010587
2015-01-08

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

#3030
20150005227
2015-01-01

METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS

#3031
20150004608
2015-01-01

MONOCYTE-DERIVED NUCLEIC ACIDS AND RELATED COMPOSITIONS AND METHODS

#3032
20150004185
2015-01-01

Prion disease-specific epitopes and methods of use thereof

#3033
20150004165
2015-01-01

Secreted proteins

#3034
20140378660
2014-12-25

Mirac proteins

#3035
20140378659
2014-12-25

OXIDIZED LDL INHIBITOR

#3036
20140378324
2014-12-25

Biosensor for detecting RAF/KSR family kinase dimerization and uses thereof

#3037
20140377339
2014-12-25

TUSC2 therapies

#3038
20140377301
2014-12-25

Vault compositions for immunization

#3039
20140377277
2014-12-25

Treatment of vasculoproliferative conditions with Lrg1 antagonists

#3040
20140377216
2014-12-25

ANTICANCER FUSION PROTEIN

#3041
20140371160
2014-12-18

Alpha-1 antitrypsin variant, preparation method thereof and use thereof

#3042
20140371154
2014-12-18

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#3043
20140371142
2014-12-18

Myonectin (CTRP15), compositions comprising same, and methods of use

#3044
20140370601
2014-12-18

Compositions for enhancing the pluripotency of stem cells

#3045
20140364483
2014-12-11

Alternative splicing variants of genes associated with prostate cancer risk and survival

#3046
20140363889
2014-12-11

Method for producing multipolar cell

#3047
20140363446
2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#3048
20140359798
2014-12-04

Correction of Crb1 mutations

#3049
20140358067
2014-12-04

Expression vector comprising a nucleotide sequence encoding a light-activated ion channel protein (VChR1) and implantable device thereof

#3050
20140357578
2014-12-04

Therapeutic approach for polyglutamine degeneration

#3051
20140357516
2014-12-04

Methods and compositions for diagnosing and treating cancer

#3052
20140356392
2014-12-04

Modulators of MYC and methods of using the same

#3053
20140356380
2014-12-04

Neutralizing antibodies and methods of use thereof

#3054
20140356344
2014-12-04

Mirac proteins

#3055
20140356327
2014-12-04

Gene therapy for neurometabolic disorders

#3056
20140356326
2014-12-04

BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY

#3057
20140349946
2014-11-27

Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein

#3058
20140349315
2014-11-27

Disulphide bond-stabilized functional soluble MHC class II heterodimers

#3059
20140348854
2014-11-27

HE4 based therapy for malignant disease

#3060
20140348832
2014-11-27

Inhibitors of T-cell activation

#3061
20140348825
2014-11-27

Compositions and methods to modulate cell activity

#3062
20140348817
2014-11-27

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

#3063
20140342994
2014-11-20

Fusion protein comprising circularly permuted form of trail/Apo2L, coding gene and use thereof

#3064
20140342401
2014-11-20

Promoter derived from human gene

#3065
20140342378
2014-11-20

PEPTIDES IMMUNOREACTIVE WITH AUTOANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS

#3066
20140341876
2014-11-20

METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN

#3067
20140341869
2014-11-20

Chimeric receptors with 4-1BB stimulatory signaling domain

#3068
20140336128
2014-11-13

Gigaxonin fusion protein and methods for treating giant axonal neuropathy

#3069
20140335561
2014-11-13

Method for producing phosphoserine incorporated proteins by using SepRS mutants and EF-Tu mutants

#3070
20140335163
2014-11-13

TARGETED IDURONATE-2-SULFATASE COMPOUNDS

#3071
20140335108
2014-11-13

UTILITY OF INSULIN-LIKE 6 (INSL6) FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#3072
20140331341
2014-11-06

Transgenic comprising a human protein with a tendency to aggregate fused to a fluorescent protein

#3073
20140331340
2014-11-06

Methods and compositions for generating a mouse

#3074
20140329742
2014-11-06

Peptide YY analogs

#3075
20140329289
2014-11-06

Anti-FH aptamers, method for producing same, and uses thereof

#3076
20140328821
2014-11-06

Vectors encoding rod-derived cone viability factor

#3077
20140328820
2014-11-06

Class of therapeutic protein based molecules

#3078
20140323983
2014-10-30

VEGF antagonist formulations for intravitreal administration

#3079
20140323411
2014-10-30

Method for De-Differentiating A Cell

#3080
20140322725
2014-10-30

Sensors and assays for ubiquitin or ubiquitin-like proteins

#3081
20140322132
2014-10-30

Fragments of p97 and uses thereof

#3082
20140317766
2014-10-23

Antibody producing non-human mammals

#3083
20140315984
2014-10-23

Methods and Compositions for Treatment of Diabetes and Related Disorders

#3084
20140315800
2014-10-23

Glycosylated polypeptide and drug composition containing said polypeptide

#3085
20140315782
2014-10-23

Methods and products for increasing frataxin levels and uses thereof

#3086
20140314836
2014-10-23

Modulation of midbody derivatives

#3087
20140314816
2014-10-23

Stabilized STAT3 decoy oligonucleotides and uses therefore

#3088
20140314772
2014-10-23

Anti-C5A binding moieties with high blocking activity

#3089
20140314768
2014-10-23

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES

#3090
20140314755
2014-10-23

Antibody producing non-human mammals

#3091
20140309405
2014-10-16

Method of producing heterogeneous protein

#3092
20140309400
2014-10-16

Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome

#3093
20140309292
2014-10-16

Mutations of histone proteins associated with proliferative disorders

#3094
20140309159
2014-10-16

Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders

#3095
20140308744
2014-10-16

Compositions of active Wnt protein

#3096
20140308262
2014-10-16

Mitochondrial proteins constructs and uses thereof

#3097
20140308259
2014-10-16

Isolated B7-H4 specific compositions and methods of use thereof

#3098
20140304846
2014-10-09

Gene and mutations thereof associated with seizure and movement disorders

#3099
20140303079
2014-10-09

Delaying the progression of diabetes

#3100
20140303020
2014-10-09

Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor

#3101
20140302592
2014-10-09

Protein purification by anion exchange chromatography

#3102
20140302527
2014-10-09

TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME

#3103
20140302094
2014-10-09

Vaccine

#3104
20140302074
2014-10-09

PAT-LM1 epitopes and methods for using same

#3105
20140302027
2014-10-09

METHODS OF TREATING PERIODONTAL INFLAMMATION AND PERIODONTAL BONE LOSS

#3106
20140302024
2014-10-09

SERUM AMYLOID P-ANTIBODY FUSION PROTEINS

#3107
20140301974
2014-10-09

Extended recombinant polypeptides and compositions comprising same

#3108
20140296487
2014-10-02

Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses

#3109
20140296154
2014-10-02

METHOD OF PREVENTING DEVELOPMENT OF PSORIATIC LESIONS

#3110
20140296129
2014-10-02

REGULATION OF RECEPTOR EXPRESSION THROUGH DELIVERY OF ARTIFICIAL TRANSCRIPTION FACTORS

#3111
20140295521
2014-10-02

METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN

#3112
20140295416
2014-10-02

Novel Method of Cancer Diagnosis and Prognosis and Prediction of Response to Therapy

#3113
20140294942
2014-10-02

ANTIVIRAL PEPTIDES EFFECTIVE AGAINST HEPATITIS C VIRUS

#3114
20140294926
2014-10-02

Treatment for exposure to nerve agent

#3115
20140294861
2014-10-02

Isolated B7-H4 specific compositions and methods of use thereof

#3116
20140294798
2014-10-02

RbAp48 transgenic mice for drug discovery in age-related memory decline

#3117
20140288281
2014-09-25

Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content

#3118
20140288145
2014-09-25

TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION

#3119
20140288008
2014-09-25

Human tear lipocalins which bind PCSK9 and methods of use thereof

#3120
20140288006
2014-09-25

PTD-SMAD7 therapeutics

#3121
20140287987
2014-09-25

Methods and compositions for the treatment of cancer or other diseases

#3122
20140287985
2014-09-25

NOVEL USES OF ELAFIN

#3123
20140287528
2014-09-25

INCORPORATION OF METHYL LYSINE INTO POLYPEPTIDES

#3124
20140287511
2014-09-25

Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells

#3125
20140286955
2014-09-25

Notch agonists for the treatment of cancer

#3126
20140275489
2014-09-18

Apelin fusion proteins and uses thereof

#3127
20140275484
2014-09-18

Method for producing factor H from a plasma precipitation fraction

#3128
20140275477
2014-09-18

Modification and compositions of human secretoglobin proteins

#3129
20140275218
2014-09-18

Wound healing compositions and treatments

#3130
20140275209
2014-09-18

Wound healing compositions and treatments

#3131
20140274915
2014-09-18

Methods of Use for Recombinant Human Secretoglobins

#3132
20140274904
2014-09-18

Inhibitors of mitochondrial fission and methods of use thereof

#3133
20140274782
2014-09-18

AFFINITY REAGENTS AND METHODS FOR DETECTION, PURIFICATION, AND PROTEOMIC ANALYSIS OF METHYLATED PROTEINS

#3134
20140274753
2014-09-18

Epigenetic biomarker ZNF545 for diagnosing and prognosis of gastric cancer

#3135
20140273227
2014-09-18

GSK3 ligands and polynucleotides encoding GSK3 ligands

#3136
20140273217
2014-09-18

Prodrug activation in cancer cells using molecular switches

#3137
20140273204
2014-09-18

Vectors encoding a paralytic peptide

#3138
20140271694
2014-09-18

ANTIGEN-SPECIFIC METHODS OF DIAGNOSING AND/OR TREATING MYOCARDITIS OR INFLAMMATORY CARDIOMYOPATHY

#3139
20140271692
2014-09-18

Immunogenic epitopes for immunotherapy

#3140
20140271640
2014-09-18

FGF-10 Complexes

#3141
20140271639
2014-09-18

Semaphorin 7a Induced Lung Fibrogenesis Occurs in a CD-4-Dependent, Macrophage Dependent Manner

#3142
20140256912
2014-09-11

Stabilized Variant MAML Peptides and Uses Thereof

#3143
20140256802
2014-09-11

Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells

#3144
20140256630
2014-09-11

VEGF-specific capture agents, compositions, and methods of using and making

#3145
20140255989
2014-09-11

Production of glycoproteins with low N-glycolylneuraminic acid (NEU5GC) content

#3146
20140255957
2014-09-11

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

#3147
20140255411
2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#3148
20140255389
2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#3149
20140255349
2014-09-11

Peptides with viral infection enhancing properties and their use

#3150
20140255310
2014-09-11

Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression

#3151
20140249208
2014-09-04

Modified polynucleotides for treating protein deficiency

#3152
20140249094
2014-09-04

SENSATION-IMPROVING AGENT

#3153
20140249081
2014-09-04

Nanoparticle peptide compositions

#3154
20140249078
2014-09-04

WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA

#3155
20140248661
2014-09-04

ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE

#3156
20140248660
2014-09-04

Heterologous intron within a signal peptide

#3157
20140248657
2014-09-04

Method for producing insoluble aggregate of neurodegenerative-disease-related protein

#3158
20140248300
2014-09-04

Peptide vaccines for cancers expressing tumor-associated antigens

#3159
20140248290
2014-09-04

Inhibition of cancer metastasis

#3160
20140242089
2014-08-28

GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF

#3161
20140242087
2014-08-28

Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders

#3162
20140242086
2014-08-28

Antibodies which bind to signal peptide-containing molecules

#3163
20140235836
2014-08-21

Immunologic Constructs and Methods

#3164
20140235823
2014-08-21

Fusion protein containing a single-stranded DNA binding protein and methods for expression and purification of the same

#3165
20140235553
2014-08-21

Compositions and methods for introduction of macromolecules into cells

#3166
20140234945
2014-08-21

TRANSTHYRETIN VARIANTS

#3167
20140234875
2014-08-21

Methods of determining efficacy of treatment in a subject having heart failure

#3168
20140234316
2014-08-21

VACCIBODIES TARGETED TO CROSS-PRESENTING DENDRITIC CELLS

#3169
20140234309
2014-08-21

Antibody-mediated transduction of heat shock proteins into living cells

#3170
20140228238
2014-08-14

Genes and polypeptides relating to breast cancers

#3171
20140227280
2014-08-14

Protein complex comprising MCM8 and MCM9 proteins and their use

#3172
20140227254
2014-08-14

Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof

#3173
20140221465
2014-08-07

Modified polynucleotides for treating galactosylceramidase protein deficiency

#3174
20140221462
2014-08-07

Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia

#3175
20140221295
2014-08-07

Modified binding proteins inhibiting the VEGF-A receptor interaction

#3176
20140220025
2014-08-07

STIP1 polypeptides and uses thereof

#3177
20140220011
2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#3178
20140220004
2014-08-07

COMPOSITIONS AND METHODS FOR TREATING PAIN

#3179
20140219988
2014-08-07

RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF

#3180
20140219974
2014-08-07

Targeted delivery of proteins across the blood-brain barrier

#3181
20140213767
2014-07-31

Haptens of paliperidone

#3182
20140213766
2014-07-31

Haptens of olanzapine

#3183
20140213638
2014-07-31

Compositions and Biomarkers for Heart Disease, Injury and Failure and Methods of Use

#3184
20140213530
2014-07-31

Methods for treatment of cancer by targeting Sirt5

#3185
20140213528
2014-07-31

Fibrosuppressant Biotherapeutics

#3186
20140213523
2014-07-31

Biglycan variant polypeptides and methods of use

#3187
20140212888
2014-07-31

T cell receptor and uses thereof

#3188
20140212438
2014-07-31

Nuclear targeting sequences

#3189
20140206852
2014-07-24

SIGNAL-SENSOR POLYNUCLEOTIDES

#3190
20140206599
2014-07-24

IL4/IL13 binding repeat proteins and uses

#3191
20140206021
2014-07-24

Prion protein ligands and methods of use

#3192
20140205588
2014-07-24

Plasminogen and plasmin variants

#3193
20140205568
2014-07-24

Drug monitoring methods using the promyelocytic leukemia protein as a redox sensor

#3194
20140200262
2014-07-17

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#3195
20140200187
2014-07-17

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#3196
20140200180
2014-07-17

METHOD FOR PRODUCING PROTEINS IN PICHIA PASTORIS THAT LACK DETECTABLE CROSS BINDING ACTIVITY TO ANTIBODIES AGAINST HOST CELL ANTIGENS

#3197
20140199371
2014-07-17

Modified polynucleotides encoding basic helix-loop-helix family member E41

#3198
20140199333
2014-07-17

Aquaporin-4 peptide compositions and methods of use thereof

#3199
20140199278
2014-07-17

Brown adipocyte modification

#3200
20140194594
2014-07-10

Synthetic peptides and peptide mimetics

#3201
20140194365
2014-07-10

Use of endostatin peptides for the treatment of fibrosis

#3202
20140194361
2014-07-10

Vault Agents for Treating Chronic Kidney Disease

#3203
20140194354
2014-07-10

Methods for treatment of nephrotic syndrome and related conditions

#3204
20140194343
2014-07-10

CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases

#3205
20140193906
2014-07-10

Screening methods for spinal muscular atrophy

#3206
20140193465
2014-07-10

α4β7 peptide dimer antagonists

#3207
20140193419
2014-07-10

Methods and compositions for treating and diagnosing diseases

#3208
20140193393
2014-07-10

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

#3209
20140187748
2014-07-03

Mirac proteins

#3210
20140186836
2014-07-03

Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis

#3211
20140186834
2014-07-03

MECP2E1 gene

#3212
20140186833
2014-07-03

CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same

#3213
20140186432
2014-07-03

Modified polynucleotides encoding citeD4

#3214
20140186379
2014-07-03

Macromolecule transduction domains and methods for identification and uses thereof

#3215
20140179611
2014-06-26

TRIBONECTINS

#3216
20140179610
2014-06-26

Treatment of myocardial injury with humanin analogs

#3217
20140179593
2014-06-26

Methods and compositions for inhibiting neddylation of proteins

#3218
20140179558
2014-06-26

Method for detecting pancreatic cancer

#3219
20140178931
2014-06-26

mTOR ligands and polynucleotides encoding mTOR ligands

#3220
20140178403
2014-06-26

Method of inhibiting binding or activity of MIF by administering a MIF antagonist

#3221
20140178380
2014-06-26

Bi-specific fusion proteins

#3222
20140178377
2014-06-26

Methods and compositions for treatment of myotonic dystrophy

#3223
20140178362
2014-06-26

METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA

#3224
20140171774
2014-06-19

Biomolecular electronic device and process of use

#3225
20140171621
2014-06-19

Galectin-Immunoglobulin Chimeric Molecules

#3226
20140171374
2014-06-19

USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS

#3227
20140165223
2014-06-12

TNF SUPERFAMILY TRIMERIZATION INHIBITORS

#3228
20140165222
2014-06-12

High affinity SUMO traps

#3229
20140165219
2014-06-12

Mutant sodium channel Nav1.7 and methods related thereto

#3230
20140162331
2014-06-12

Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof

#3231
20140162306
2014-06-12

Polymutant tau protein variants and their use for recapitulating human tauopathies

#3232
20140162296
2014-06-12

Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof

#3233
20140162293
2014-06-12

Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency

#3234
20140162292
2014-06-12

Reagent for diagnosing tumor, pharmaceutical composition, and screening method

#3235
20140162259
2014-06-12

Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathies

#3236
20140161873
2014-06-12

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

#3237
20140157444
2014-06-05

WDR13 as a novel biomarker useful for treating diabetes and cancer

#3238
20140155331
2014-06-05

High affinity bivalent helically constrained peptide against cancer

#3239
20140155326
2014-06-05

EGFR and C-Met fibronectin type III domain binding molecules

#3240
20140155325
2014-06-05

EGFR and c-Met fibronectin type III domain binding molecules

#3241
20140155324
2014-06-05

NOVEL PEPTIDES AND USES THEREOF IN THERAPEUTIC METHODS

#3242
20140155315
2014-06-05

Synthetic linear apelin mimetics for the treatment of heart failure

#3243
20140154744
2014-06-05

Compositions and methods for making selenocysteine containing polypeptides

#3244
20140154238
2014-06-05

Compositions and methods for treating, diagnosing and monitoring disease

#3245
20140148397
2014-05-29

Appetite stimulating protein

#3246
20140147844
2014-05-29

Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia

#3247
20140147456
2014-05-29

CETP fragments

#3248
20140147432
2014-05-29

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#3249
20140147426
2014-05-29

Anticaries compositions and probiotics/prebiotics

#3250
20140147421
2014-05-29

Method of treating diabetes by a CTRP12 polypeptide

#3251
20140142369
2014-05-22

Dairy cattle breeding for improved milk production traits in cattle

#3252
20140142046
2014-05-22

Wnt compositions and therapeutic uses of such compositions

#3253
20140141445
2014-05-22

Isolated Mammalian Monocyte Cell Genes; Related Reagents

#3254
20140141444
2014-05-22

Isolated Mammalian Monocyte Cell Genes; Related Reagents

#3255
20140141068
2014-05-22

Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1

#3256
20140141067
2014-05-22

Modified polynucleotides encoding septin-4

#3257
20140141064
2014-05-22

HLA-A2 tumor associated antigen peptides and compositions

#3258
20140141027
2014-05-22

Peptide vaccines for cancers expressing tumor-associated antigens

#3259
20140135945
2014-05-15

Polymer nanofiber scaffold for a heparin/fibrin based growth factor delivery system

#3260
20140135275
2014-05-15

Mitochondrial targeting and therapeutic use thereof

#3261
20140135272
2014-05-15

NOVEL ZINC FINGER-LIKE PEPTIDE COMPOSITIONS AS POTENT AGENTS IN CANCER PREVENTION AND TREATMENT

#3262
20140134624
2014-05-15

Methods, compositions, and kits for detecting protein aggregates

#3263
20140134276
2014-05-15

Anti-tumor drug, medicament, composition, and use thereof

#3264
20140134237
2014-05-15

Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis

#3265
20140134198
2014-05-15

EphA2 T-cell epitope agonists and uses therefore

#3266
20140128569
2014-05-08

Method for acquiring a heat-stable antibody-displayed phage

#3267
20140128324
2014-05-08

Methods and compositions for the treatment of cancer or other diseases

#3268
20140128316
2014-05-08

INTEGRASE COFACTOR

#3269
20140127811
2014-05-08

Methods and compositions for gene inactivation

#3270
20140127681
2014-05-08

Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport

#3271
20140127678
2014-05-08

Mapping cytosine modifications

#3272
20140127677
2014-05-08

Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid

#3273
20140127129
2014-05-08

Dimeric binding proteins based on modified ubiquitins

#3274
20140121167
2014-05-01

Therapeutic peptides and use thereof against huntington's disease

#3275
20140120579
2014-05-01

METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION

#3276
20140120059
2014-05-01

IMMUNITY INDUCING AGENT

#3277
20140113960
2014-04-24

Modified polynucleotides encoding granulysin

#3278
20140113959
2014-04-24

MODIFIED POLYNUCLEOTIDES ENCODING CASPASE 6

#3279
20140113857
2014-04-24

Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

#3280
20140113830
2014-04-24

Azoline compound and azole compound library and method for producing same

#3281
20140113370
2014-04-24

Fc fusion proteins comprising novel linkers or arrangements

#3282
20140113330
2014-04-24

Modified vitamin K-dependent polypeptides

#3283
20140107322
2014-04-17

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

#3284
20140107189
2014-04-17

Modified polynucleotides encoding apoptosis inducing factor 1

#3285
20140106365
2014-04-17

MULTIPROTEIN ASSEMBLIES

#3286
20140105966
2014-04-17

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

#3287
20140105965
2014-04-17

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

#3288
20140105964
2014-04-17

Modified polynucleotides encoding aquaporin-5

#3289
20140105906
2014-04-17

Peptide for protection of allergic respiratory disorders

#3290
20140100356
2014-04-10

Immunoglobulin-binding polypeptide

#3291
20140099668
2014-04-10

Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides

#3292
20140099313
2014-04-10

Interleukin-13 binding proteins

#3293
20140099310
2014-04-10

CANCER TARGETS AND USES THEREOF

#3294
20140096273
2014-04-03

Mouse for predicting a behavior of drugs in humans

#3295
20140094595
2014-04-03

Protein Scaffolds for Antibody Mimics and Other Binding Proteins

#3296
20140094416
2014-04-03

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#3297
20140094411
2014-04-03

Method of purifying proteins

#3298
20140094384
2014-04-03

STROMAL ANTIGEN 2 (STAG2) COMPOSITIONS AND METHODS

#3299
20140093524
2014-04-03

Modified chaperonin 10

#3300
20140093521
2014-04-03

Therapeutic DLL4 binding proteins